Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · N970003/S309

ESSENTIO SR SL (L100); ESSENTIO DR SL (L101); ESSENTIO DR EL (L121); PROPONENT SR SL (L200); PROPONENT DR SL (L201)

Boston Scientific Corp · Decision date Jul 23, 2026

FDA DECISIONN970003/S309

What did the FDA decide?

FDA records N970003/S309 as a supplement to PMA null, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 23, 2026.

FDA approval order statement

to add a functionally equivalent alternate vapor degreasing solvent used to remove contaminants from pulse generator components
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Jul 23, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
N970003/S309
Regulatory pathway
PMA supplement
Product code
LWP
Decision code
OK30
Decision date
Jul 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable pulse generator, pacemaker (non-CRT).

Product code
LWP
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. N970003/S309 received

    Application receipt date recorded by FDA.

  2. N970003/S309 · FDA decision

    30-Day Notice

Related devices and submissions

Explore the linked device profile

Other records with product code LWP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific Corp

Headquarters
Not reported
FDA applicant address
4100 Hamline Ave. N, St Paul, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records